Using AI to read kidney cancer CT scans for better staging
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study uses a computer program (deep learning) to look at your kidney CT scan and tell if your cancer is more advanced (stage T3) or earlier (stage T1-T2). The goal is to help doctors plan the best treatment for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have had surgery to remove your kidney cancer, and it was confirmed as renal cell carcinoma (RCC) in the lab.
- You had a contrast-enhanced CT scan before surgery at Peking University First Hospital, with very thin slices (1 mm or less).
- Your cancer stage after surgery is either pT1a, pT1b, pT2a, pT2b (cancer still inside the kidney) or pT3a (cancer has spread just outside the kidney).
- Your CT images are clear and free of major artifacts or blurring.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses artificial intelligence to help plan the best surgery for kidney tumors. You may be eligible if you have a kidney tumor that can be removed with surgery and have had a special CT scan within the past month.
This trial uses artificial intelligence to look at ultrasound and other scans to better stage bladder cancer and predict if chemotherapy before surgery might work. It may help doctors plan your treatment more precisely.
This study uses MRI scans to help doctors better identify the type and severity of kidney tumors. It may lead to more accurate diagnoses without needing extra tests.
This study tests whether artificial intelligence (AI) can help doctors tell kidney tumors apart from non-cancerous growths using a regular CT scan without contrast dye. If the AI works well, it could help doctors make better decisions without the need for extra procedures.
This study uses computers to learn from CT scans of kidney tumors. It may help doctors better understand and treat these tumors. You might be eligible if you have a kidney tumor and have had a contrast CT scan.
This trial uses artificial intelligence to read CT scans and predict how well kidney cancer patients will do after surgery. It aims to help doctors plan better treatment for you.
Hear when a new Diagnostic Imaging trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.